Lisata Therapeutics, Inc. Common Stock

LSTANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
1.06 USD
↗ 0.06 (6.44%)AT CLOSE (03:59 PM EDT)
1.04
↘ 0.02 (1.98%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
1.04
↘ 0.02 (1.98%)
🔴Market: CLOSED

Lisata Therapeutics, Inc. Common Stock (LSTA) is currently trading at $1.05. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. LSTA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 26, 2026.

Open?$0.98
High?$1.06
Low?$0.96
Prev. Close?$1.00
Volume?60.3K
Avg. Volume?212.4K
VWAP?$1.02
Rel. Volume?0.28x
Bid / Ask
Bid?$0.97 × 100
Ask?$1.28 × 400
Spread?$0.31
Midpoint?$1.13
Valuation & Ratios
Market Cap?11.5M
Shares Out?10.8M
Float?7.4M
Float %?82.5%
P/E Ratio?N/A
P/B Ratio?1.39
EPS?-$1.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
21
Market Cap
10.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lisata.com
Listed
1999-03-01
Address
110 ALLEN ROAD
BASKING RIDGE, NJ 07920
Phone: 908-229-2590
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-74.40Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.39%Low
Short Interest?28.8K
Days to Cover?1.0
Free Float7.4M
Avg Daily Volume151.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.69Strong
Quick Ratio?3.69Strong
Cash Ratio?3.50Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
90
1.39CHEAP▾
P/S?
Peers
100
S&P
3
114.52HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
Peers
100
S&P
10
10.09HIGH▾
Returns & Efficiency
ROE?
S&P
3
-177.4%WEAK▾
ROA?
S&P
3
-132.6%WEAK▾
Cash Flow & Enterprise
FCF?$-12323000
Enterprise Value?$1.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist